The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Daily Flow Intestinal Transit
Chelidonium majus 3C, Raphanus sativus 3C, Rhamnus frangula 3C · CHELIDONIUM MAJUS WHOLE .1 mg/100mL; RAPHANUS SATIVUS .1 mg/100mL; FRANGULA ALNUS BARK .1 mg/100mL · Spray · Buccal · Sevene Usa
NDC 76472-7008-02 · 1 BOTTLE, SPRAY in 1 BOX / 30 mL in 1 BOTTLE, SPRAY · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Chelidonium majus 3C, Raphanus sativus 3C, Rhamnus frangula 3C (Spray)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Sevene Usa | CHELIDONIUM MAJUS WHOLE .1 mg/100mL; RAPHANUS SATIVUS .1 mg/100mL; FRANGULA ALNUS BARK .1 mg/100mL | Aug 26, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Daily Flow Intestinal Transit — NDC 76472-7008-02," retrieved September 3, 2026, https://drugdashboards.com/drug/76472700802.
Free to cite with attribution — see how the data is put together.